We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMCI icon
26
Treace Medical Concepts
TMCI
$284M
$36.8M 0.64%
6,260,000
+49,000
+0.8% +$319K
KURA icon
27
Kura Oncology
KURA
$826M
$35.8M 0.62%
6,200,000
-372,000
-6% -$2.28M
GOOGL icon
28
Alphabet (Google) Class A
GOOGL
$4.08T
$33.6M 0.58%
190,400
-106,600
-36% -$17.4M
OFIX icon
29
Orthofix Medical
OFIX
$477M
$33.2M 0.57%
2,978,000
+14,000
+0.5% +$173K
BHVN icon
30
Biohaven
BHVN
$2.08B
$30.1M 0.52%
2,136,000
+462,578
+28% +$8.24M
RIGL icon
31
Rigel Pharmaceuticals
RIGL
$704M
$30M 0.52%
1,600,000
+84,000
+6% +$1.59M
AUTL
32
Autolus Therapeutics
AUTL
$407M
$27.4M 0.47%
12,000,000
+1,000,000
+9% +$1.65M
PENN icon
33
PENN Entertainment
PENN
$2.75B
$25.3M 0.44%
1,413,588
-1,672,469
-54% -$26.2M
AVNS
34
DELISTED
Avanos Medical
AVNS
$24.9M 0.43%
2,036,000
+36,000
+2% +$453K
PFGC icon
35
Performance Food Group
PFGC
$18B
$24.5M 0.42%
280,000
-45,691
-14% -$3.81M
DYN icon
36
Dyne Therapeutics
DYN
$4.8B
$24.4M 0.42%
2,560,000
-208,000
-8% -$2.29M
IRON icon
37
Disc Medicine
IRON
$3.03B
$23.1M 0.4%
436,000
– –
ADBE icon
38
Adobe
ADBE
$98.5B
$23.1M 0.4%
59,587
-51,613
-46% -$19.9M
MDT icon
39
Medtronic
MDT
$110B
$23M 0.4%
264,000
-277,237
-51% -$23.5M
EAT icon
40
Brinker International
EAT
$9B
$22.7M 0.39%
125,827
+28,093
+29% +$4.41M
S icon
41
SentinelOne
S
$6.31B
$22.6M 0.39%
1,235,484
-630,317
-34% -$11.5M
PLNT icon
42
Planet Fitness
PLNT
$4.43B
$21.8M 0.38%
200,039
-147,519
-42% -$14.8M
MDB icon
43
MongoDB
MDB
$26.2B
$21.7M 0.38%
103,496
+58,531
+130% +$10.8M
IMCR icon
44
Immunocore
IMCR
$1.72B
$21.3M 0.37%
678,000
-300,000
-31% -$9.32M
IBRX icon
45
ImmunityBio
IBRX
$7.8B
$20.5M 0.35%
+7,764,000
New +$20.9M
CHDN icon
46
Churchill Downs
CHDN
$5.76B
$20.2M 0.35%
200,153
+24,845
+14% +$2.43M
DDOG icon
47
Datadog
DDOG
$95.6B
$20.1M 0.35%
150,000
-90,000
-38% -$9.96M
BCYC
48
Bicycle Therapeutics
BCYC
$280M
$19.5M 0.34%
2,800,000
+128,000
+5% +$1.02M
CMG icon
49
Chipotle Mexican Grill
CMG
$48.8B
$18.3M 0.32%
325,847
+211,847
+186% +$10.8M
SNN icon
50
Smith & Nephew
SNN
$13.6B
$16M 0.28%
522,038
-1,246,962
-70% -$35.2M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.